A Part of the University of Maryland Medical Center

• Description
• Stage Explanation
• Treatment Option Overview
• Hydatidiform Mole
• Placental-Site Gestational Trophoblastic Tumors
• Nonmetastatic Gestational Trophoblastic Tumors
• Good Prognosis Metastatic Gestational Trophoblastic Tumors
• Poor Prognosis Metastatic Gestational Trophoblastic Tumors
• Recurrent Gestational Trophoblastic Tumors
• To Learn More About Gestational Trophoblastic Tumors

• Gynecologic Oncology Program

• Diagnostic and Treatment Services
• Physicians and Staff
• Patient Education...
• Schedule an Appointment
• 
    Related Resources
• Baltimore City Cancer Program
• Cigarette Restitution Fund Program
• Clinical Trials
• Information for Patients

Hydatidiform Mole

Treatment may be one of the following:

Following surgery, the doctor will follow the patient closely with regular blood tests to make sure the level of beta-HCG in the blood falls to normal levels. If the blood level of beta-HCG increases or does not go down to normal, more tests will be done to see whether the tumor has spread. Treatment will then depend on whether the patient has nonmetastatic disease or metastatic disease (see the treatment sections on metastatic or nonmetastatic disease).

Check for U.S. clinical trials from NCI's list of cancer clinical trials that are now accepting patients with hydatidiform mole. For more specific results, refine the search by using other search features, such as the location of the trial, the type of treatment, or the name of the drug. General information about clinical trials is available from the NCI Web site.